KUBACKI RAYMOND C JR

Average Profitability
38.08%
Insider Buys Quantity
7
Insider Buys Sum
$64,104.00
Insider Sells Quantity
4
Insider Sells Sum
$562,574.75

Insider Activity of KUBACKI RAYMOND C JR

The largest purchase of all time was on 2017-11-14 and amounted to 1000 shares of Psychemedics Corporation for $16,880.

The largest sale of all time was on 2005-03-29 and amounted to 18700 shares of Psychemedics Corporation for $252,738.

Biography of KUBACKI RAYMOND C JR

No biography is available at this moment.

2020-12-08PurchasePsychemedics Corporation
PMD
Chairman, CEO & President
1,000
0.0181%
$5.00$5,000+41.2%
2020-11-12PurchasePsychemedics Corporation
PMD
Chairman, CEO & President
2,000
0.0366%
$3.86$7,720+83.33%
2019-06-14PurchasePsychemedics Corporation
PMD
Chairman, CEO & President
1,000
0.0181%
$9.99$9,990-7.75%
2017-11-14PurchasePsychemedics Corporation
PMD
Chairman, CEO & President
1,000
0.0182%
$16.88$16,880+20.17%
2015-09-14PurchasePsychemedics Corporation
PMD
Chairman, CEO & President
1,000
0.0184%
$9.99$9,995+35.96%
2015-09-10PurchasePsychemedics Corporation
PMD
Chairman, CEO & President
1,000
0.0185%
$10.25$10,250+32.77%
2009-03-06PurchasePsychemedics Corporation
PMD
Chairman, CEO & President
1,000
0.0204%
$4.27$4,269+60.89%
2005-04-04SalePsychemedics Corporation
PMD
Chairman, CEO and President
5,200
0.1007%
$13.20$68,640+6.89%
2005-04-01SalePsychemedics Corporation
PMD
Chairman, CEO and President
1,600
0.0311%
$13.37$21,392+5.67%
2005-03-29SalePsychemedics Corporation
PMD
Chairman, CEO and President
18,700
0.3637%
$13.52$252,738+4.01%
2005-03-22SalePsychemedics Corporation
PMD
Chairman, CEO and President
16,050
0.3151%
$13.70$219,805+3.19%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.